Abstracts tagged "Lupus and treatment"

Abstract Number: 2651 • 2018 ACR/ARHP Annual Meeting
Patients Characteristics and Patters of Treatment in Refractory Systemic Lupus Erythematosus Patients in the Pre-Biologic Period: Data from a Multiethnic, Multinational Latin American Lupus Cohort
Guillermo J. Pons-Estel^1,2, Marina Scolnik³, Enrique R Soriano³, Guillermina Harvey⁴, Rosana Quintana^5,6, Mercedes Garcia⁷, Verónica Saurit⁸, Cristina Drenkard⁹, Guillermo Berbotto¹⁰, Emilia Sato¹¹, Lilian Costallat¹², Eloisa Bonfa¹³, Eduardo Ferreira Borba¹⁴, Joao C. Tavares Brenol¹⁵, Nilzio A. da Silva¹⁶, Andre Cavalcanti¹⁷, Antonio Iglesias-Gamarra¹⁸, Marlene Guibert-Toledano¹⁹, Gil A. Reyes¹⁹, Loreto Massardo²⁰, Oscar Neira²¹, Mario H Cardiel²², Leonor Barile²³, Mary Carmen Amigo²⁴, Luis H. Silveira²⁵, Ignacio Garcia de la Torre²⁶, Rosa Maria Serrano⁶, Eduardo Acevedo-Vasquez²⁷, Manuel Ugarte-Gil²⁷, Ines Segami²⁸, Viviana Gervasoni⁵, Silvana Conti⁵, Rosa Chacón-Díaz²⁹, Maria H Esteva-Spinetti³⁰ and Bernardo A Pons-Estel⁶, ¹Rheumatology, Hospital Provincial de Rosario, Rosario, Argentina, ²Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario. Argentina, Rosario, Argentina, ³Rheumatology Unit, Internal Medicine Service. Hospital Italiano Buenos Aires. Argentina, Buenos Aires, Argentina, ⁴Escuela de Estadística, Universidad Nacional de Rosario, Rosario, Argentina, ⁵Hospital Provincial de Rosario, Rosario, Argentina, ⁶Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Rosario, Argentina, ⁷Rheumatology, HIGA General San Martin La Plata, La Plata, Argentina, ⁸Hospital Privado Centro Médico de Córdoba, Cordoba, Argentina, ⁹Medicine/Rheumatology, Emory University, Atlanta, GA, ¹⁰Sanatorio Británico, Rosario, Argentina, ¹¹Rheumatology Division, Universidade Federal de Sao Paulo, Sao Paulo, Brazil, ¹²Universidade Estadual da Campinas, Campinas, Brazil, ¹³Rheumatology Division, Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil, ¹⁴Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, ¹⁵Hospital da Clinicas da Porto Alegre, Porto Alegre, Brazil, ¹⁶Universidade Federal de Goiás, Goiânia, Brazil, ¹⁷Novartis, Sao Paulo, Brazil, ¹⁸Clinical Development, Nordic Bioscience, Herlev, Denmark, ¹⁹Centro de Investigaciones Médico-Quirúrgicas (CIMEQ), Havana, Cuba, ²⁰GLADEL, Santiago, Chile, ²¹Rheumatology Section., Hospital del Salvador, Universidad de Chile., Santiago, Chile, ²²Centro de Investigación Clínica de Morelia, Morelia, Mexico, ²³Hospital Ángeles del Pedregal, Mexico, Mexico, ²⁴Rheumatology, Centro Medico ABC, Mexico, Mexico, ²⁵Rheumatology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City DF, Mexico, ²⁶Hospital General de Occidente, Guadalajara, Mexico, ²⁷Hospital Guillermo Almenara Irigoyen. EsSalud, Lima, Peru, ²⁸Hospital Edgardo Rebagliati Martins. EsSalud, Lima, Peru, ²⁹Servicio de Reumatología, Hospital Universitario de Caracas, Centro Nacional de Enfermedades Reumáticas, Caracas, Venezuela, ³⁰Hospital Central de San Cristóbal, San Cristóbal, Venezuela, San Cristóbal, Venezuela (Bolivarian Republic of)
Background/Purpose: Over the last few years, the importance of treating patients with systemic lupus erythematosus (SLE) towards achieving Remission or Low Disease Activity State has…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].